Status:
WITHDRAWN
Effect of Tranexamic Acid on Prevention of Recurrence of Hemoptysis
Lead Sponsor:
Seoul National University Hospital
Conditions:
Hemoptysis
Eligibility:
All Genders
25-75 years
Phase:
PHASE3
Brief Summary
Hemoptysis is one of the serious complication of many pulmonary diseases. Upto now, there is no proven medical treatment in recurrence of hemoptysis. The investigators will conduct a randomized, place...
Eligibility Criteria
Inclusion
- age: \>=20 and \<=75
- ER visit or admission for hemoptysis
- no evidence of hemoptysis on screening
Exclusion
- anticoagulation treatment
- Cr \>= 2.0 mg/dL or urinary protein \>= 2+ or who received renal replacement treatment
- hepatic failure: total bilirubin \>= 1.5 mg/dL or AST or ALT \>= 1.5 of upper normal limit level
- hypersensitivity to tranexamic acid
- pregnant woman
- fertile female who don't use contraception
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01167764
Start Date
July 1 2011
End Date
December 1 2013
Last Update
January 7 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, South Korea
2
Seoul National University Hospital
Seoul, South Korea, 110-744
3
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Seoul, South Korea